We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Early Infection Therapy Reduces ICU Mortality

By HospiMedica staff writers
Posted on 19 Nov 2001
A study has found that patients given aggressive treatment for severe sepsis and septic shock in the emergency department (ED) in the first six hours before admission to the intensive care unit (ICU) have lower death rates, less risk of organ failure, and spend less time in the hospital. More...
Conducted by researchers at the Henry Ford Hospital (Detroit, MI, USA), the study was published in the November 8, 2001, issue of The New England Journal of Medicine.

The study involved 263 patients, of whom 133 were treated with standard care and 130 with an aggressive intervention called early goal-directed therapy (EGDT). Treatment in the EGDT group was guided by an eight-inch fiber optic catheter inserted into the heart to detect decreases in oxygen delivery to vital organs. Patients in this group received fluid and heart medications. Patients in the other group received routine treatment base on physical exam, vital signs, blood pressure, and urine output. They also received a standard catheter inserted in the heart to measure blood pressure instead of blood oxygen levels.

Patients in the EGDT group had a mortality rate of 30.5%, compared to 46.5% in the standard care group. The EGDT group also had a substantially lower incidence of organ failure and spent less time in the hospital. The researchers say that standard diagnostic methods fail to detect significant decreases in oxygen delivery to vital organs in the early stages of severe infection. Severe sepsis and septic shock account for as many deaths every year as heart attacks in the United States.

"The treatment shown to be effective in this study is generally routine in the intensive care unit,” said Emanuel P. Rovers, M.D., director of research at Henry Ford's department of emergency medicine and the lead author of the study. "But we've shown that the treatment is even more effective when applied at earlier stages in the emergency department.




Related Links:
Henry Ford Hospital

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Mammography System (Analog)
MAM VENUS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.